phycoerythrin (PE)-conjugated (Miltenyi Biotec). Primary mixed leukocyte cultures (MLC) 9 with irradiated CD34 þ or CD133 þ cells and allogeneic T cells showed a comparable allostimulatory activity, further confirmed by the upregulation of activation markers on T cells such as CD25, CD69 and OX-40 on allo-T cells (Figures 1a and b ).
Then, we tested whether the stimulation of progenitor cells with allo-T cells for 1 or 24 h would affect the clonogenic activity (CFU-C) 8 of CD34 þ or CD133 þ cells in vitro (Figure 1c ). In the absence of T cells, CD133 þ cells generated a moderately smaller number of erythroid colonies (BFU-E) compared with CD34 þ cells (P ¼ 0.1, n ¼ 3 experiments). When CD133 þ cells were stimulated with autologous or allogeneic T cells for 24 h the number of BFU-E significantly increased (P ¼ 0.01) (n ¼ 5 experiments). On the contrary, stimulation with T cells did not modify the number of erythroid colonies in cultures with CD34 þ cells. No effect of priming with T cells was observed in other lineages.
When we looked at the expression of CD80 (not shown) and CD86 costimulatory molecules on CD133 þ cells, CD80 was observed in o1% of cells and CD86 in o2%. However, like our previous observations in experiments with CD34 þ cells, 9 upon stimulation with allo-T cells, CD133 þ cells upregulated the expression of CD86 to B5% at 24 h and 20% at 6 days of in vitro culture, as shown in Figure 1d . To test the function of these cells, CD133 þ cells that had been stimulated with T cells for 6 days were then harvested, irradiated and tested as stimulators in a MLC 9 with third party T-cell responders. CD133 þ cells that had been stimulated with T cells for 6 days showed a fourfold greater APC activity than unstimulated CD133 þ cells (P ¼ 0.0003) (n ¼ 3 experiments) (Figure 1e) . A similarly increased APC activity was observed in control experiments with CD34 þ cells (data not shown).
Our results demonstrate for the first time the allostimulatory activity of CD133 þ hematopoietic stem cells in vitro. In addition, in a similar model previously observed with CD34 þ cells, we show that CD133 þ hematopoietic progenitors increase their (c) CD133 þ , CD34 þ or autologous MNC were irradiated and tested as stimulators in primary MLR with alloresponders at 1:2 ratio. T-cell alloreactivity was measured by 3H-thymidine assay. 9 The results are shown as mean
The expression of marker of T-cell activation, such as CD69, CD25 and CD134 (OX-40) was assessed by 3-color flow cytometry experiments on CD3 þ T cells before (black column) and after 6-day co-culture with irradiated CD133 þ (dark gray) or CD34 þ cells (light gray). These results are shown as mean±s.d. of three separate experiments. (e) Clonogenic activity of CD133 þ and CD34 þ cells upon stimulation with/without allogeneic (allo) or autologus (auto) lymphocytes. CD133 þ or CD34 þ cells were cultured for 1 or 24 h with or without autologous or allogeneic lymphocytes, and then were plated in methylcellulose medium containing cytokines. After 12-14 days, cultures were scored for the presence of CFU-GM, BFU-E and CFU-mix colonies. The results are shown as the mean ± s.d. of five separate experiments. Results were statistically analyzed by t-test and no significant differences were observed within CD133 þ or CD34 þ cell experiments (with or without auto or allo-T cells), nor comparing CD34 þ with CD133 þ cells. However, a trend for a reduced number of BFU-E was noted comparing colonies obtained with freshly isolated CD133 þ vs CD34 þ cells (P ¼ 0.1). (f) Increased APC activity of CD133 þ cells upon contact with allogeneic MNC. Freshly isolated CB CD133 þ cells were harvested and analyzed by flow cytometry for constituitive CD86 expression (day 0). CD133 þ cells were then incubated with irradiated (3 Gy) allogeneic T cells for 24 h (day 1) or 6 days (day 6). Expression of CD86 was analyzed on gated CD133 þ cells (n ¼ 3 experiments). (g) Irradiated CD133 þ cells (day 0) were used as stimulators in a primary MLR with allogeneic T cells. The same cells were also incubated with irradiated alloresponders and on day 6 were harvested, irradiated and tested as stimulators 9 in MLC (S:R ¼ 1:2) with the same alloresponders used in the initial MLR (CD133 day 6). The results show an increased APC activity of CD133 þ cells after exposure to allo-T cells for 6 days (P ¼ 0.0003). T-cell proliferation was measured by 3H-thymidine uptake and the results represent mean±s.d., of three separate experiments. 10 demonstrated that CB CD133 þ cells were induced to differentiate into DCs over 10-18 days in vitro and that only in the presence of transforming growth factor-b could they achieve a complete maturation of DC with APC activity. Previously, we hypothesized that after an allo-SCT an amplification loop may exist, where the cross-talk between donor CD34 þ progenitors and host T cells may result in the expansion and differentiation of CD34-derived APC and the proliferation of alloreactive T cells, which could then bind to more CD34 þ cells recruiting more APCs from the engrafting stem cells. 9 As the majority of CD133 þ cells are also CD34 þ , our results further characterize the subset of hematopoietic progenitors with APC activity residing within CD34 þ CD133 þ hematopoietic precursors that can rapidly both stimulate T-cell responses and differentiate into more mature APC, thus enhancing T-cell contact and activation.
Finally, we also demonstrate here that the clonogenic activity in vitro of CD34 þ and CD133 þ cells is comparable in the presence of allo-T cells. In conclusion, the results of this study do not favor selection of CD133 þ cells, based on immunogenic or clonogenic function, for allo-SCT. Further in vivo studies are required to understand the impact of these findings in the clinical setting of allo-SCT.
